Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details